Earnings Report Digest

Abbott Laboratories (ABT), 2025 Q2 earnings digest

1 min Β· 18 jul 2025
aflevering Abbott Laboratories (ABT), 2025 Q2 earnings digest artwork

Beschrijving

$ABT has released its Q2 2025 earnings, where EPS of $1.26 met expectations while revenue reached $11.14B, reflecting a 7.37% year-over-year increase. Despite a 1.5% decline in diagnostics sales, particularly in COVID testing, other divisions showed resilience with medical devices growing by 12%. Key risks include ongoing headwinds from COVID impacts and geopolitical issues in China. Future opportunities hinge on product advancements, especially in diabetes care and biosimilars. πŸ“Šβœ¨ For more details, check valueverge.com/ABT.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Earnings Report Digest community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. Β· Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

469 afleveringen